Myths and Facts About Glimepiride

Glimepiride is either used as monotherapy or in combination with metformin or insulin for effective control of hyperglycemia in people with type 2 diabetes mellitus. In spite of its effective glucose-lowering potential, similar to other sulfonylureas, glimepiride has been associated with several myths like cardiovascular risk, hypoglycemic effects, weight gain, beta-cell failure, risk in special populations of diabetic patients, and effects of metabolites. Here, we will discuss the myths and facts associated with glimepiride and its safety and concern issues